MetLife, Inc. Issues Preliminary Variable Investment Income Update Ahead of Q1 2026 Earnings

MetLife, Inc. (NYSE: MET) has released a Current Report on Form 8-K to provide preliminary information regarding its variable investment income for the first quarter ended March 31, 2026, ahead of the Company’s scheduled quarterly earnings release on May 6, 2026.

Key Highlights for Investors

• Preliminary Variable Investment Income Estimate: For Q1 2026, MetLife estimates its variable investment income to be approximately \$475 million to \$525 million (pre-tax).
• Comparison to Guidance: This preliminary result is provided in the context of MetLife’s full-year 2026 guidance of approximately \$1.6 billion (pre-tax) for variable investment income.
• Components of Variable Investment Income: The figure includes income from private equity, real estate, other funds, and prepayment fees.
• Timing of Earnings Release: The full Q1 2026 earnings report and financial supplement are scheduled to be released on May 6, 2026.

Important Information for Shareholders

• This update is preliminary and unaudited: The numbers disclosed are based on preliminary results available to management and have not yet undergone the Company’s full financial closing procedures. Actual results may differ materially.
• Potential Impact on Share Price: Variable investment income is a significant driver of MetLife’s earnings, especially given the importance of alternative asset returns (e.g., private equity, real estate) to insurers in the current environment. The estimated income for Q1 represents roughly 30% of the full-year guidance, suggesting a strong start to 2026—this may influence investor sentiment and trading activity in the near term.
• Forward-Looking Statements and Risks: The company notes that these estimates are subject to risks and uncertainties, and actual results could be materially different. Investors should consider the forward-looking nature of this disclosure and reference the Company’s risk factors in SEC filings.

Stock and Security Information

• MetLife’s Common Stock trades on the New York Stock Exchange (NYSE) under the symbol MET.
• The company also has several series of preferred shares trading under the symbols MET PRA (Series A), MET PRE (Series E), and MET PRF (Series F), all on the NYSE.

Other Regulatory and Compliance Notes

• This 8-K is filed under Item 7.01 Regulation FD Disclosure, meaning it is intended to provide broad, non-selective disclosure of material information.
• The information in this filing is not considered “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 and should not be incorporated by reference in other filings unless expressly stated.

Executive Sign-Off

The report is signed by Adrienne O’Neill, Executive Vice President and Chief Accounting Officer, on behalf of METLIFE, INC.

Disclaimer: This article is based on preliminary, unaudited financial information disclosed by MetLife, Inc. in a Form 8-K filing. The information is subject to change after the Company completes its quarter-end financial closing process. Investors should exercise caution, consider the risks and uncertainties highlighted by MetLife, and review official filings and releases for the most up-to-date information before making investment decisions.

View METLIFE INC Historical chart here